SCHEMBL4476526

SCHEMBL4476526

Nc1cc(F)ccc1NC(=O)c1ccc(CNC(=O)/C=C/c2ccccc2)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 19/20 1.00
HDAC3 O15379 8/20 1.00
HDAC2 Q92769 7/20 1.00
NCOR2 Q9Y618 4/20 1.00
HDAC10 Q969S8 3/20 0.79
HDAC11 Q96DB2 3/20 0.79
HDAC8 Q9BY41 3/20 0.79
HDAC4 P56524 2/20 0.79
HDAC7 Q8WUI4 2/20 0.79
HDAC6 Q9UBN7 2/20 0.79
HDAC9 Q9UKV0 2/20 0.79
HDAC5 Q9UQL6 2/20 0.79
NAMPT P43490 2/20 0.79
NCOR1 O75376 1/20 0.68
KCNH2 Q12809 1/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4476529 1.00 HDAC1 (1.00) HDAC1HDAC3HDAC2NCOR2HDAC10
SCHEMBL6842698 0.92 HDAC1 (0.85) HDAC1HDAC3HDAC2NCOR2HDAC10
SCHEMBL6842697 0.92 HDAC1 (0.85) HDAC1HDAC3HDAC2NCOR2HDAC10
Tucidinostat SCHEMBL29350211 0.89 HDAC1 (1.00) HDAC1HDAC3HDAC2NCOR2HDAC10
Tucidinostat SCHEMBL29813059 0.89 HDAC1 (1.00) HDAC1HDAC3HDAC2NCOR2HDAC10
Tucidinostat SCHEMBL13815849 0.89 HDAC1 (1.00) HDAC1HDAC3HDAC2NCOR2HDAC10
Tucidinostat SCHEMBL4483082 0.89 HDAC1 (1.00) HDAC1HDAC3HDAC2NCOR2HDAC10
SCHEMBL28462845 0.86 HDAC1 (0.76) HDAC1HDAC3HDAC2NCOR2HDAC10
SCHEMBL12633337 0.82 HDAC1 (0.78) HDAC1HDAC3HDAC2NCOR2HDAC10
SCHEMBL28458251 0.81 HDAC1 (0.68) HDAC1HDAC3HDAC2NCOR2HDAC10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11377423-B2 Inhibitors of histone deacetylase THE BROAD INSTITUTE, INC. (US) 2022-07-05 US disclosed
US-20180072671-A1 INHIBITORS OF HISTONE DEACETYLASE THE BROAD INSTITUTE, INC. (US) 2018-03-15 US disclosed
US-9790184-B2 Inhibitors of histone deacetylase THE BROAD INSTITUTE, INC. (US) 2017-10-17 US disclosed
US-20150191427-A1 INHIBITORS OF HISTONE DEACETYLASE THE GENERAL HOSPITAL CORPORATION D/B/A MASSACHUSETTS GENERAL HOSPITAL (US) 2015-07-09 US disclosed
EP-2877444-A1 INHIBITORS OF HISTONE DEACETYLASE The Broad Institute, Inc. (US) 2015-06-03 EP disclosed
WO-2014018979-A1 INHIBITORS OF HISTONE DEACETYLASE THE BROAD INSTITUTE, INC. (US) 2014-01-30 WO disclosed
US-7550490-B2 Benzamide derivatives as histone deacetylase inhibitors with potent differentiation and anti-proliferation activity SHENZHEN CHIPSCREEN BIOSCIENCES LTD. (CN) 2009-06-23 US disclosed
US-7550490-B2 Benzamide derivatives as histone deacetylase inhibitors with potent differentiation and anti-proliferation activity SHENZHEN CHIPSCREEN BIOSCIENCES LTD. (CN) 2009-06-23 US disclosed
US-7550490-B2 Benzamide derivatives as histone deacetylase inhibitors with potent differentiation and anti-proliferation activity SHENZHEN CHIPSCREEN BIOSCIENCES LTD. (CN) 2009-06-23 US disclosed
US-20080039509-A1 Histone Deacetylase Inhibitors or Novel Benzamine Derivatives with Potent Differentiation and Anti-Proliferation Activity SHENZHEN CHIPSCREEN BIOSCIENCES, LTD. 2008-02-14 US disclosed
US-20080039509-A1 Histone Deacetylase Inhibitors or Novel Benzamine Derivatives with Potent Differentiation and Anti-Proliferation Activity SHENZHEN CHIPSCREEN BIOSCIENCES, LTD. 2008-02-14 US disclosed
US-20080039509-A1 Histone Deacetylase Inhibitors or Novel Benzamine Derivatives with Potent Differentiation and Anti-Proliferation Activity SHENZHEN CHIPSCREEN BIOSCIENCES, LTD. 2008-02-14 US disclosed
US-7244751-B2 Histone deacetylase inhibitors of novel benzamide derivatives with potent differentiation and anti-proliferation activity SHENZHEN CHIPSCREEN BIOSCIENCES LTD. (CN) 2007-07-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180072671-A1 INHIBITORS OF HISTONE DEACETYLASE HDAC3, HDAC1, HDAC11 HDAC1 2/4885HDAC3 1/4885HDAC2 5/4885
US-20080039509-A1 Histone Deacetylase Inhibitors or Novel Benzamine Derivatives with Potent Differentiation and Anti-Proliferation Activity HDAC5, HDAC1, HDAC7 HDAC1 2/4885HDAC3 12/4885HDAC2 8/4885
US-20150191427-A1 INHIBITORS OF HISTONE DEACETYLASE HDAC3, HDAC1, HDAC5 HDAC1 2/4885HDAC3 1/4885HDAC2 5/4885
US-11377423-B2 Inhibitors of histone deacetylase HDAC3, HDAC1, HDAC11 HDAC1 2/4885HDAC3 1/4885HDAC2 5/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.